Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)
CUSIP: 55234L105
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 1,644,695
- Total 13F shares
- 7,560,014
- Share change
- -1,037,213
- Total reported value
- $87,616,000
- Price per share
- $11.59
- Number of holders
- 49
- Value change
- -$11,848,887
- Number of buys
- 23
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 55234L105?
CUSIP 55234L105 identifies LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 55234L105:
Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
196%
|
3,222,561
|
$36,737,000 | — | 31 Dec 2020 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
67%
|
1,100,852
|
$12,550,000 | — | 31 Dec 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
50%
|
815,849
|
$9,301,000 | — | 31 Dec 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
50%
|
815,364
|
$9,295,000 | — | 31 Dec 2020 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
47%
|
775,888
|
$8,845,000 | — | 31 Dec 2020 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
28%
|
456,138
|
$5,199,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
16%
|
264,165
|
$3,012,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
12%
|
191,000
|
$2,177,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
173,723
|
$1,980,000 | — | 31 Dec 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
5.3%
|
87,353
|
$996,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
77,646
|
$885,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.2%
|
68,517
|
$781,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
4.1%
|
67,995
|
$775,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.7%
|
61,310
|
$699,000 | — | 31 Dec 2020 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
3%
|
50,000
|
$570,000 | — | 31 Dec 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3%
|
49,000
|
$559,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.7%
|
44,020
|
$502,000 | — | 31 Dec 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2.4%
|
39,167
|
$447,000 | — | 31 Dec 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
2.2%
|
36,392
|
$415,000 | — | 31 Dec 2020 | |
| Pentwater Capital Management LP |
13F
|
Company |
1.4%
|
23,800
|
$271,000 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.4%
|
22,510
|
$257,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.3%
|
21,648
|
$246,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.2%
|
19,450
|
$222,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.86%
|
14,179
|
$162,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.86%
|
14,177
|
$162,000 | — | 31 Dec 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.85%
|
14,049
|
$160,000 | — | 31 Dec 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.74%
|
12,226
|
$139,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.66%
|
10,832
|
$123,000 | — | 31 Dec 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.63%
|
10,287
|
$117,000 | — | 31 Dec 2020 | |
| Altium Capital Management LLC |
13F
|
Company |
0.32%
|
5,218
|
$59,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.29%
|
4,772
|
$54,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.27%
|
4,438
|
$51,000 | — | 31 Dec 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.24%
|
3,954
|
$45,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
3,617
|
$41,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.21%
|
3,521
|
$40,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.14%
|
2,334
|
$27,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.11%
|
1,885
|
$21,000 | — | 31 Dec 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.09%
|
1,450
|
$17,000 | — | 31 Dec 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.08%
|
1,265
|
$14,000 | — | 31 Dec 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.07%
|
1,138
|
$12,000 | — | 31 Dec 2020 | |
| STRS OHIO |
13F
|
Company |
0.07%
|
1,100
|
$12,000 | — | 31 Dec 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.05%
|
759
|
$9,000 | — | 31 Dec 2020 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0.02%
|
363
|
$4,000 | — | 31 Dec 2020 |
Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q1 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.